Phototherapy compositions and methods

Details Phototherapy compositions and methods Phototherapy compositions and methods

2005-12-19

2011-11-15

Richter, Johann (Department: 1616)

Drug, bio-affecting and body treating compositions

Topical sun or radiation screening, or tanning preparations

C424S400000, C424S401000

Reexamination Certificate

active

08057785

ABSTRACT:
Compositions containing a photoactivable agent and an agent that absorbs or blocks extraneous radiation during phototherapy are useful and used in methods to treat leukocyte mediated autoimmune diseases such as psoriasis, CTCL, and vertiligo.

REFERENCES:
patent: 4321919 (1982-03-01), Edelson
patent: 4387089 (1983-06-01), DePolo
patent: 4994263 (1991-02-01), Lang et al.
patent: 5169624 (1992-12-01), Ziegler et al.
patent: 5399719 (1995-03-01), Wollowitz et al.
patent: 5405868 (1995-04-01), Goupil
patent: 5556612 (1996-09-01), Anderson et al.
patent: 5962512 (1999-10-01), Goupil et al.
patent: 6420570 (2002-07-01), Wollowitz et al.
patent: 6469052 (2002-10-01), Wollowitz et al.
patent: 6552286 (2003-04-01), Yang et al.
patent: 1097224 (1981-03-01), None
patent: 148440 (1981-05-01), None
patent: 6069014 (1985-04-01), None
patent: 8133964 (1996-05-01), None
Kawada, A. et al., “An Evaluation of Broad-Spectrum Sunscreens Against Topical Puva-Induced Erythema”, ACTA Dermato-Venereologica, vol. 69, No. 4, 1989, pp. 335-337.
Takeuchi, T. et al., “A Novel in Vivo Model for Evaluating Agents that Protect Against Ultraviolet A-Induced Photoaging”, Journal of Investigative Dermatology, New York, New York, US, vol. 110, Apr. 1998, pp. 343-347.
Walter, J.F. et al., “Psoralen-Containing Sunscreen Induces Phototoxicity and Epidermal Omithine Decarboxylase Activity”, Journal of the American Academy of Dermatology 1982 United States, vol. 6, No. 6, 1982, pp. 1022-1027.
Rippke, F. et al., “PUVA Therapy of Psoriases—Test Model and Field of Application for UVA Protective Medicinal Sunscreens”, H+G Zeitschrift Fur Hautkrankheiten 1994 Germany, vol. 69, No. 10, 1994, pp. 671-676.
European Search Report, dated Apr. 5, 2006, for European Appln. No. 05 25 8014.
Cripps, D.J. et. al., 1982.Action spectra of topical psoralens: a re-evaluation, British Journal of Dermatology 107, 77-82.
Edelson, R. et. al., 1987.Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy, New England Journal of Medicine, 316:297.
Edelson, R. et. al., 1988.Light-activated Drugs, Scientific American. p. 68-75.
Fahmy, I.R. et al, 1948.Ammi Majus Linn: Pharmacognostical Study and Isolation of Crysallie Constituent, ammoidin. Quant. J. Pharmac. And Pharmacol. 20:281.
Frederiksson, T. et al, 1978.Severe Psoriasis—Oral Therapy with a New Retinoid, Dermatologica 157:238-244.
Gilchrest, B.A., et al., 1976.Oral Methoxsalen Photochemotherapy of Mycosis fungoides. Cancer 38:683-689.
Honigsmann, Herbert et al., 1984.Photochemotherapy for cutaneous T cell lymphoma. J. American Academy of Dermatology 10:238-245.
Rhodes, L.E. et al., 2000.Guidelines for topical PUVA: a report of a workshop of the British Photodermatology Group. 142:22-31.
Martens-Lobenhoffer, J. et al., 1999. Long-term Stability of 8-Methoxypsoralen in Oinitments for topical PUVA therapy (Cream-PUVA). 12:266-270.

Affiliated with

Also associated with

Rating

Phototherapy compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phototherapy compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phototherapy compositions and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4310229